Description

Fisiocrem Solugel is a topical pain‑relief and anti‑inflammatory gel presented in a 250 g tube. Formulated with plant‑derived active ingredients and menthol, it helps relieve mild muscle pain and soreness, assists recovery from soft tissue injuries (sprains and strains), supports post‑exercise recovery, helps reduce inflammation and swelling, assists healing of bruises, and may relieve mild muscle spasms or twitches. The non‑greasy gel absorbs well and imparts a cooling sensation on application.

Active ingredients and actions

• Arnica montana: Traditionally used to help reduce bruising and muscle soreness.
• Calendula officinalis: Supports skin comfort and tissue recovery.
• Hypericum perforatum: Used for soft‑tissue and nerve‑related discomfort.
• Menthol: Provides an immediate cooling effect and mild counter‑irritant sensation.
• Melaleuca alternifolia (tea tree): Contributes to skin comfort.

Indications and benefits

• Helps relieve mild muscle pain and soreness
• Assists relief of soft tissue injuries, sprains and strains
• Helps reduce inflammation and swelling
• Supports post‑exercise recovery
• Assists healing of bruises
• May relieve mild muscle spasms or twitches

Features

• Non‑greasy gel that absorbs well
• Cooling sensation on application (menthol)
• Suitable for adults and children aged 3+ years
• May be used alongside blood‑thinning medications (per manufacturer guidance); consult a healthcare professional if unsure

Directions for use

• Apply a few grams to the affected area 3–4 times daily or as required
• Gently massage until absorbed
• Allow full absorption before dressing to help avoid staining

Typical application areas

• Back, shoulders, neck, calves, thighs, glutes, biceps, forearms

Precautions

• For external use only
• Do not apply to broken skin
• Avoid contact with eyes
• Patch test if you have sensitive skin
• Consult a GP for children under 3 years
• If symptoms persist, seek medical advice
• Always read the label and follow the directions for use

Clinical support

• The manufacturer cites a randomized, double‑blind, placebo‑controlled study reporting reduced pain and improved mobility within minutes, with continued improvement over 14 days. Individual responses can vary.

Regulatory information (Australia)

• Listed medicine on the Australian Register of Therapeutic Goods (ARTG ID 392192)
• Sponsor: Pronat Group Australia Pty Ltd
• Therapeutic good type: Medicines
• ARTG entry date: 13 July 2022
• Licence category: LI; Licence status: A